Effects of chitosan nanoparticle supplementation on growth performance, humoral immunity, gut microbiota and immune responses after lipopolysaccharide challenge in weaned pigs. Issue 2 (30th December 2019)

• Record Type: Journal Article
• Authors: Xu, Yinglei; Mao, Huiling; Yang, Caimei; Du, Huahua; Wang, Haifeng; Tu, Jue
• Is Part Of: Journal of animal physiology and animal nutrition. Volume 104:Issue 2(2020)
• Page Start: 597
• Page End: 605
• Publication Date: 2019-12-30
• Subjects: chitosan nanoparticles -- growth performance -- immune status -- immunological stress -- intestine ecology -- weaned piglets; Animal nutrition -- Periodicals; Feeds -- Periodicals; 636.085
• DOI: 10.1111/jpn.13283
• Languages: English
• ISSNs: 0931-2439

Abstract

Abstract: In this study, we aimed to determine the effects of dietary supplementation with chitosan nanoparticles (CNP) on growth performance, immune status, gut microbiota and immune responses after lipopolysaccharide challenge in weaned pigs. A total of 144 piglets were assigned to four groups receiving different dietary treatments, including basal diets supplemented with 0, 100, 200 and 400 mg/kg CNP fed for 28 days. Each treatment group included six pens (six piglets per pen). The increase in supplemental CNP concentration improved the average daily gain (ADG) and decreased the feed and gain (F/G) and diarrhoea rate ( p < .05). However, significant differences in the average daily feed intake (ADFI) among different CNP concentrations were not observed. CNP also increased plasma immunoglobulin (Ig)A and IgG, and C3 and C4 concentrations in piglets in a dose‐dependent manner on day 28, whereas IgM concentration was not affected by CNP. A total of 24 piglets in the control diet and control diet with 400 mg/kg CNP supplementation groups were randomly selected for the experiment of immunological stress. Half of the pigs in each group ( n = 6) were injected i.p . with Escherichia coli lipopolysaccharide (LPS) at a concentration of 100 μg/kg. The other pigs in each group were injected with sterile saline solution at the same volume. Plasma concentrations of cortisol, prostaglandin E2 (PEG2), interleukin (IL)‐6, tumour necrosis factor (TNF)‐α and IL‐1β dramatically increased after LPS challenge. However, CNP inhibited the increase in cortisol, PEG2, IL‐6 and IL‐1β levels in plasma, whereas TNF‐α level slightly increased. Moreover, the effects of CNP on the gut microbiota were also evaluated. Our results showed that dietary supplementation with CNP modified the composition of colonic microbiota, where it increased the amounts of some presumably beneficial intestinal bacteria and suppressed the growth of potential bacterial pathogens. These findings suggested CNP supplementation improved the growth performance and immune status, alleviated immunological stress and regulated intestinal ecology in weaned piglets. Based on these beneficial effects, CNP could be applied as a functional feed additives supplemented in piglets diet.